Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 1, 2011, Pages 175-180

  Kahn, Shannon ^a   Flowers, Christopher ^a   Xu, Zhiheng ^a   Esiashvili, Natia ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

High dose chemotherapy; Involved field radiotherapy; Refractory relapsed Hodgkin lymphoma; Stem cell transplantation; Toxicity analysis

Indexed keywords

CASE-CONTROL; DISEASE PROGRESSION; FAILURE RATE; HAZARD RATIO; HIGH-DOSE CHEMOTHERAPIES; INVOLVED FIELD RADIOTHERAPY; PROGNOSTIC INDICATORS; RADIATION FIELD; REFRACTORY/RELAPSED HODGKIN LYMPHOMA; STEM CELL TRANSPLANTATION;

CHEMOTHERAPY; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; STEM CELLS; TOXICITY;

DISEASE CONTROL;

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ADOLESCENT; ADULT; AGE; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DYSPHAGIA; ESOPHAGOBRONCHIAL FISTULA; FEMALE; FOLLOW UP; HISTOLOGY; HODGKIN DISEASE; HUMAN; INVOLVED FIELD RADIOTHERAPY; LUNG FIBROSIS; MALE; MYELITIS; NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RELAPSE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; ETOPOSIDE; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; RECURRENCE; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 79961127127     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.010     Document Type: Article

References (31)

1. L.R. Prosnitz, L.R. Farber, and D.S. Kapp Combined modality therapy for advanced Hodgkin's disease: 15-Year follow-up data J Clin Oncol 6 1988 603 610
2. P.G. Visani, G. Meloni, and G. Cimino High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian study group report J Clin Oncol 6 1988 1411 1416 (Pubitemid 19089029)
3. L.A. Dawson, N.G. Saito, and V. Ratanatharathorn Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease Int J Radiat Oncol Biol Phys 59 2004 208 218 (Pubitemid 38501526)
4. A.R. Yuen, S.A. Rosenberg, and R.T. Hoppe Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease Blood 89 1997 814 822 (Pubitemid 27121274)
5. R.T. Hoppe, R.H. Advani, and P.J. Bierman Hodgkin disease/lymphoma: Clinical practice guidelines in oncology J Natl Compr Canc Netw 4 2006 210 230 (Pubitemid 44265362)
6. D.D. Weisenburger, A. Kessinger, and E.C. Reed Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease Am J Med 91 1991 605 611
7. G. Visani, G. Meloni, and G. Cimino High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian study group report J Clin Oncol 6 1988 1411 1416 (Pubitemid 19089029)
8. R. Chopra, A.K. McMillan, and D.C. Linch The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients Blood 81 1993 1137 1145 (Pubitemid 23067347)
9. M. Crump, A.M. Smith, and J. Brandwein High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease; importance of disease status at transplant J Clin Oncol 11 1993 704 711 (Pubitemid 23105679)
10. S.J. Homing, R.S. Negrin, and N.J. Chao Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non Hodgkin's lymphoma J Clin Oncol 12 1994 2552 2558 (Pubitemid 24379638)
11. S. Jagannath, J.O. Armitage, and K.A. Dicke Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease J Clin Oncol 7 1989 179 185 (Pubitemid 19048450)
12. R.J. Jones, S. Piantadosi, and R.B. Mann High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease J Clin Oncol 8 1990 527 537 (Pubitemid 20087554)
13. A. Kessinger, P.J. Bierman, and J.M. Vose High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin disease Blood 77 1991 2322 2325
14. T. Philip, F. Dumont, and D. Teillet High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease Br Cancer 53 1986 737 742 (Pubitemid 16082029)
15. G.L. Phillips, S.N. Wolff, and R.H. Herzig Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation Blood 73 1989 2086 2092 (Pubitemid 19179538)
16. A.P. Rapoport, J.M. Rowe, and P.A. Kouides One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome J Clin Oncol 11 1993 2351 2361
17. D.E. Reece, M.J. Barnett, and J.M. Connors Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease J Clin Oncol 9 1991 1871 1879
18. D.E. Reece, J.M. Connors, and J.J. Spinelli Intensive therapy with cyclophospamide, carmustine, etoposide, cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy Blood 83 1994 1193 1199 (Pubitemid 24062841)
19. J. Yahalom, S.C. Gulati, and M. Toia Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease J Clin Oncol 11 1993 1062 1070 (Pubitemid 23163345)
20. A.J. Mundt, G. Sibley, and S. Williams Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease Int J Radiat Oncol Biol Phys 33 1995 261 270
21. D.M. Brizel, E.P. Winter, and L.R. Prosnitz Improved survival in advanced Hodgkin's disease with the use of combined modality therapy Int J Radiat Oncol Biol Phys 1990 19535 19542
22. C.J. Fabian, C.M. Mansfield, and S. Dahlberg Low-dose involved fieldradiation after chemotherapy in advanced Hodgkin disease Ann Intern Med 120 1994 903 912
23. J. Yahalom, J. Ryu, and D.J. Straus Impact of adjuvant radiation on the patterns and rate of relapse in advanced stage Hodgkin's disease treated with alternating chemotherapy combinations J Clin Oncol 9 1991 2193 2201
24. J.C. Poen, R.T. Hoppe, and S.J. Horning High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival Int J Radiat Oncol Biol Phys 36 1996 3 12 (Pubitemid 26314146)
25. J.M. Vose, P.J. Bierman, and J.R. Anderson Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up Blood 80 1992 2142 2148
26. R. Pezner, A. Nademanee, and J. Niland Involved field radiation therapy for Hodgkin's disease autologous bone marrow transplantation regimens Radiother Oncol 34 1995 23 29
27. P. Wadhwa, D.C. Shina, and D. Schenkein Should involvedfield radiation therapy be used as an adjunct to lymphoma autotransplantation? Bone Marrow Transplant 29 2002 183 189 (Pubitemid 34189509)
28. H. Gatcombe, J. Lawson, S. Phuphanich, and I. Crocker Treatment related myelitis in Hodgkin's lymphoma following stem cell transplant, chemotherapy and radiation: A case report and review of the literature J Neurooncol 79 2006 293 298 (Pubitemid 44363733)
29. K.A. Goodman, E. Riedel, and V. Serrano Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma J Clin Oncol 26 2008 5240 5247
30. L. Specht 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas Semin Radiat Oncol 17 2007 190 197 (Pubitemid 46963030)
31. J.E. Filmont, C. Gisselbrecht, and X. Cuenca The impact of pre- and post-transplantation positron emission tomography using 18-flourodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation Cancer 110 2007 1361 1369 (Pubitemid 47435610)